Skip to content

Measuring hepatic steatosis with ultrasound and MRS in children with overweight or obesity

Measuring hepatic steatosis with ultrasound and MRS in children with overweight or obesity - Hepatic steatosis in children with overweight

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54724
Enrollment
54
Registered
2018-01-08
Start date
2020-08-20
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver disease Non-alcoholic fatty liver disease

Interventions

None listed

Sponsors

Maastricht Universitair Medisch Centrum +
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria:  · Participation in the COACH program · Aged below 18 years 

Exclusion criteria

Exclusion criteria:  · Steatosis on liver ultrasonography · Elevated liver transaminase levels above two times the upper limit of normal  (>44 U/L for girls and > 52 U/L for boys) · Implanted medical devices such as pacemakers or neurostimulators · Metal objects in the body (for instances prosthetics, piercings, metal parts  in the eye, permanent eyeliner) · Previous brain surgery · Cardiac arrhythmia · Epilepsy · Claustrofobia · Not wanting to be informed about accidental findings on MRS 

Design outcomes

Primary

MeasureTime frame
Ultrasonographic hepato-renal index and liver fat percentage as determined by magnetic resonance spectroscopy.

Secondary

MeasureTime frame
Metabolic and anthropometric parameters, to correlate with the measured liver parameters (for example waist-circumference, lipids, blood pressure and glucose metabolism). The goal is to gain more insight into which children can be identified as being at-risk for developing NAFLD based on their cardiometbolic profile.

Countries

Netherlands

Contacts

Public ContactA.C.E. Vreugdenhil

Maastricht Universitair Medisch Centrum +

a.vreugdenhil@mumc.nl0433875284

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)